期刊文献+

盐酸右美托咪啶在全身麻醉腹部手术拔管期的应用 被引量:4

下载PDF
导出
摘要 目的:观察盐酸右美托咪啶在全身麻醉腹部手术后拔管期间对生命体征的影响。方法:选择40例在全身麻醉下行腹部手术的患者,随机分成盐酸右美托咪啶(A)组和0.9%氯化钠溶液(B)组,分别于手术结束前30 min给药,记录全麻诱导前、注射药物前、拔除气管导管时,以及拔除气管导管后5和10 min的平均动脉压(MAP)、心率(HR)及血氧饱和度(SpO2),比较两组的差异。结果:与注射药物前相比,A组MAP、HR及SpO2较平稳,各时间点差异无统计学意义(P>0.05);B组拔除气管导管时及拔除气管导管后5、10 min时的MAP、HR均较注射药物前以及A组同时间点显著升高(P<0.05),A、B两组的苏醒时间及SpO2的差异无统计学意义(P>0.05)。结论:盐酸右美托咪啶应用于全身麻醉腹部手术患者拔管期,可有效维持呼吸、循环稳定,不影响患者的苏醒。
作者 吴伟强
出处 《贵阳医学院学报》 CAS 2013年第4期404-405,407,共3页 Journal of Guiyang Medical College
  • 相关文献

参考文献7

  • 1石碧明,任永功,张雪萍,李亚丽,陶明哲,张中军.不同处理方法对全麻手术病人气管拔管应激反应的影响[J].中华麻醉学杂志,2005,25(7):501-504. 被引量:53
  • 2Hartley M, Vaughan RS. Problems associated with trache- al extubation [J]. 1Br J Anaesth, 1993(4) :561 -568.
  • 3庄心良,曾因明,陈伯銮.现代麻醉学[M].北京:人民卫生出版社,2004∶ 7.
  • 4阳兴,黄漫,顾文彤.右美托咪啶对瑞芬太尼复合丙泊酚靶控输注麻醉苏醒期的影响[J].国际医药卫生导报,2010,16(11):1336-1338. 被引量:22
  • 5MacDonald E, Scheinin M. Distribution and pharmaeolo-gy of alpha 22 adrenoceptors in the central nervous system [J] . J Physiol Pharmacol, 1995(3) :241 -258.
  • 6Coursin DB, Coursin DB, Maecioli GA. Dexmedetomi- dine [J]. Curr Opin Crit Care, 2001(4) : 221 -226.
  • 7Mcnda F, Kner O, Sayin M, ctal. etomidinc as an adjunct to anesthetic induction to attenuate hemodynamic re- sponse toendotrachcal intubation in patients undergoing fast- track CABG[J]. Ann Card Anaesth, 2010 (1):16-21.

二级参考文献15

  • 1Campistol JM,Sacks SH.Mechanisms of nephrotoxicity[J].Transplan tation,2006,69(3):555-560.
  • 2Scheinin B,Lindgren L,Randell T,et al.Dexmedetomidine attenu-ates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl[J].Br J Anaesth,1992,68(10):126-131.
  • 3Talke P,ChenR,ThomasB,et al.The hemodynamic and adrenergic effects ofperioperative dexmedetomidine infusion after vascular surgery[J].Anesth Analg,2000,90(7):834-839.
  • 4TaittonenMT,Kirvela OA,Aantaa R,et al.Effect of clonidine and dexmedetomidine premedication on perioperative oxygen consumption and haemodynamic state[J].Br J Anaesth,1997,78(2):400-406.
  • 5Khan ZP,Munday IT,JonesRM,et al.Effects of dexmedetomidine on isoflurane requirements in healthy volunteers.1:Pharmacodynamic and pharmacokinetic interactions[J].Br JAnaesth,1999,83(5):372-380.
  • 6Levanen J,MakelaML,ScheininH.Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanes-thetic delirium[J].Anesthesiology,1995,82(12):1117-1125.
  • 7Peden CJ,Cloote AH,Stratford N,et al.The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil[J].An-aesthesia,2001,56(11):408-413.
  • 8JaakolaML,SalonenM,Lehtinen R.et al.The analgesic action of dexmedetomidine-a novel α 2-adrenoceptor agonist?in healthy volunteers[J].Pain,1991,46(7):281-285.
  • 9Zalunardo MP, Zollinger A, Spahn DR, et al. Effects of intravenous and oral clonidine on hemodynamic and plasma-catecholamine response due to endotracheal intubation. J Clin Anesth, 1997,9:143-147.
  • 10Imai Y, Mammoto T, Murakami K, et al. The effects of preanesthetic oral clonidine on total requirement of propofol for general anesthesia. J Clin Anesth, 1998,10: 660-665.

共引文献271

同被引文献20

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部